MAPT and Alzheimer disease: Indirubin is also a potent cyclin-dependent kinase inhibitor which is neuroprotective, attenuates high fat-high fructose induced Aβ-aggregation, and prevents tau-phosphorylation in Alzheimer’s disease animal models [54,55,56,57,58,59,60].